TRU fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. It offers Truscreen Cervical Cancer screening system, which is designed to detect the presence in real time of pre-cancerous and cancerous tissue on the cervix by using optical and electrical measurements of cervical tissue. The company was founded on November 6, 2013 and is headquartered in Auckland, New Zealand.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
TRU has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company